Friday, October 26, 2018

Biotech IPOs For The Week Ahead

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing ophthalmic products under 505(b)(2) regulatory pathway. Eton is a spin-out company of Imprimis Pharmaceuticals, Inc. (IMMY).

from RTT - Biotech https://ift.tt/2Oa0el8
via IFTTT

No comments:

Post a Comment